Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PD1 Blockade and Oncolytic Virus in Relapsed Multiple Myeloma

NCT03605719 is registered in ClinicalTrials.gov with Emory University as lead sponsor.

NCT NCT03605719
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03605719 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PD1 Blockade and Oncolytic Virus in Relapsed Multiple Myeloma
Lead sponsor
Emory University
Phase
Phase 1
Overall status
Completed
Start date
October 24, 2018
Completion date
October 10, 2022
Enrollment
23 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent plasma cell myeloma